Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)
Contact +33 (0)3 90 20 54 70

? Special Offer?Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

? New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Lenzilumab Biosimilar – Anti-CSF2 mAb – Research Grade

Clonality:
Monoclonal Antibody
Isotype:
IgG1, kappa

€200.00

100ug +200 loyalty points
Size
Clear
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery
Lenzilumab Biosimilar - Anti-CSF2 mAb binds to Human CSF2/GM-CSF in indirect ELISA Assay
Lenzilumab Biosimilar - Anti-CSF2 mAb - Research Grade

Lenzilumab Biosimilar - Anti-CSF2 mAb - Research Grade

Product name Lenzilumab Biosimilar - Anti-CSF2 mAb - Research Grade
Source CAS 1229575-09-0
Species Homo sapiens
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Lenzilumab,KB-003,CSF2,anti-CSF2
Reference PX-TA1360
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1-kappa
Clonality Monoclonal Antibody
Product name Lenzilumab Biosimilar - Anti-CSF2 mAb - Research Grade
Source CAS 1229575-09-0
Species Homo sapiens
Expression system Mammalian cells
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Lenzilumab,KB-003,CSF2,anti-CSF2
Reference PX-TA1360
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG1-kappa
Clonality Monoclonal Antibody

General information on Anti-CSF2[Homo sapiens] (Lenzilumab) Monoclonal Antibody

Lenzilumab is investigated for the treatment of Chronic Myelomonocytic Leukemia (CMML).

Lenzilumab Biosimilar - Anti-CSF2 mAb binds to Human CSF2/GM-CSF in indirect ELISA Assay

Lenzilumab Biosimilar - Anti-CSF2 mAb binds to Human CSF2/GM-CSF in indirect ELISA Assay

Immobilized CSF2 / GM-CSF (in Mammalian), C-His, recombinant protein (cat. No. PX-P5667) at 0.5µg/mL (100µL/well) can bind Lenzilumab Biosimilar - Anti-CSF2 mAb (cat. No. PX-TA1360) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 33.07M.

Lenzilumab Biosimilar - Anti-CSF2 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

There are no reviews yet.

Be the first to review “Lenzilumab Biosimilar – Anti-CSF2 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products